ClearPoint Neuro CLPT Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 61.4%+0.5pp | 60.9%+4.1pp | 56.8%-9.0pp | 65.8%-2.3pp | |
| Operating margin | -65.4%-2.5pp | -62.9%+30.8pp | -93.7%-14.2pp | -79.5%+2.6pp | |
| Net margin | -69.1%-8.8pp | -60.3%+32.0pp | -92.2%-12.2pp | -80%+8.4pp | |
| EBITDA margin | -63.2%-3.4pp | -59.7%+31.3pp | -91.1%-12.8pp | -78.3%+2.8pp | |
| Free cash flow margin | -66.1%-36.7pp | -29.4%+30.9pp | -60.3%+19.6pp | -79.9%-1.0pp | |
| Returns | |||||
| Return on equity | -95.6%-14.4pp | -81.2%-5.2pp | -76.1%-37.7pp | -38.4%+18.0pp | |
| Return on assets | -37.3%+8.9pp | -46.2%-1.2pp | -45%-17.9pp | -27.1%+3.2pp | |
| Return on invested capital | -100.4%+89.1pp | -189.5%-54.4pp | -135.1%-19.3pp | -115.7%+82.7pp | |
| Efficiency | |||||
| Asset turnover | 0.5×-0.2× | 0.8×+0.3× | 0.5×+0.1× | 0.3×0.0× | |
| Inventory turnover | 3.4×-46.8× | 50.2×+25.4× | 24.7×+10.3× | 14.5×+11.7× | |
| Liquidity | |||||
| Current ratio | 5.9×+2.7× | 3.2×-1.6× | 4.9×-2.7× | 7.5×-5.5× | |
| Quick ratio | 5.1×+1.9× | 3.2×-1.6× | 4.8×-2.7× | 7.5×-5.4× | |
| Cash ratio | 4.4×+2.4× | 1.9×-1.2× | 3.1×-1.0× | 4.1×-7.3× | |
| Leverage | |||||
| Debt-to-equity | 2.1×+1.9× | 0.1×-0.5× | 0.7×+0.3× | 0.3×+0.1× | |
| Debt-to-assets | 0.6×+0.5× | 0.1×-0.2× | 0.3×+0.1× | 0.2×0.0× | |
| Per Share | |||||
| Book value per share | $0.99+5.3% | $0.94+9.2% | $0.86-43.6% | $1.53-35.2% | |
| Valuation | |||||
| Market capitalization | $538.61M+69.2% | $424.25M+154% | $167.17M-19.6% | $207.98M-21.6% | |
| Enterprise value | $565.68M+82.9% | $407.72M+158% | $157.97M-17.9% | $192.35M-13.9% | |
| Price / sales | 13.3×+3.4× | 13.5×+6.5× | 7×-3.1× | 10.1×-6.2× | |
| Price / book | 28.6×+12.7× | 16.7×+8.8× | 7.9×+2.3× | 5.6×+0.2× | |
| EV / sales | 13.9×+4.3× | 13×+6.4× | 6.6×-2.8× | 9.4×-4.3× | |
| Free cash flow yield | -5%-1.3pp | -2.2%+6.5pp | -8.6%-0.7pp | -7.9%-3.0pp | |
| Earnings yield | -5.4%+1.1pp | -4.5%+8.8pp | -13.2%-5.3pp | -7.9%-2.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are ClearPoint Neuro's profit margins?
- ClearPoint Neuro (CLPT) runs a 62.3% gross margin and a -65.2% operating margin, with a -71.6% net margin.
- Where do ClearPoint Neuro's ratios come from?
- Every ratio is computed from ClearPoint Neuro's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
